- |||||||||| Enrollment change, Trial termination, Trial primary completion date, FDG PET: Early Diagnosis of Alzheimer-like Dementia: Benefit of MRI and PET Imaging (clinicaltrials.gov) - Mar 10, 2015
P=N/A, N=60, Terminated, N=350 --> 60 | Suspended --> Terminated | Trial primary completion date: Jul 2014 --> Apr 2013; Administrative re-organization of the department. Referent physician left the hospital.
- |||||||||| TTP4000 / vTv Therapeutics
Trial completion, Enrollment change, Trial primary completion date: A Safety Study of TTP4000 in Subjects With Alzheimer's Disease (clinicaltrials.gov) - Feb 12, 2015 P1, N=8, Completed, Trial primary completion date: Mar 2015 --> Dec 2015 Active, not recruiting --> Completed | N=16 --> 8 | Trial primary completion date: Sep 2012 --> Feb 2013
- |||||||||| midodrine hydrochloride / Generic mfg.
Enrollment closed, Trial primary completion date: Body Temperature in Persons With Tetraplegia When Exposed to Cold (clinicaltrials.gov) - Feb 5, 2015 P4, N=30, Active, not recruiting, Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Dec 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2014 --> Feb 2015
- |||||||||| Leqembi (lecanemab-irmb) / Biogen, BioArctic, Eisai
Enrollment closed, Trial primary completion date, IO biomarker: A Randomized, Double-blind, Placebo-controlled Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamic Response of Repeated Intravenous Infusions of BAN2401 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease (clinicaltrials.gov) - Jan 26, 2015 P1, N=24, Active, not recruiting, Trial primary completion date: Jul 2014 --> Jul 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Mar 2015
- |||||||||| Kisunla (donanemab-azbt) / Eli Lilly
Trial primary completion date: A Study of LY3002813 in Participants With Alzheimer's Disease (clinicaltrials.gov) - Dec 19, 2014 P1, N=100, Recruiting, N=400 --> 300 | Trial primary completion date: Sep 2014 --> Sep 2016 Trial primary completion date: May 2015 --> Aug 2015
- |||||||||| Trial primary completion date: Cognitive Impairment and Balance in Elderly (clinicaltrials.gov) - Dec 10, 2014
P=N/A, N=100, Recruiting, Recruiting --> Completed Trial primary completion date: Oct 2014 --> Jan 2015
- |||||||||| minocycline / Generic mfg.
Trial completion, Enrollment change: Minocycline in Patients With Alzheimer's Disease (clinicaltrials.gov) - Sep 28, 2014 P2, N=13, Completed, Trial primary completion date: Aug 2014 --> Mar 2015 Recruiting --> Completed | N=120 --> 13
|